Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.

Gopinathannair R, Birks EJ, Trivedi JR, McCants KC, Sutton BS, Deam AG, Slaughter MS, Hottigoudar RU.

J Card Fail. 2015 Mar;21(3):226-32. doi: 10.1016/j.cardfail.2014.12.006. Epub 2014 Dec 17.

PMID:
25528199
2.

Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.

Bartoli CR, Ghotra AS, Pachika AR, Birks EJ, McCants KC.

Thorac Cardiovasc Surg. 2014 Aug;62(5):414-8. doi: 10.1055/s-0034-1376891. Epub 2014 Jul 4.

PMID:
24995532
3.

The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.

Donneyong M, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter MS.

ASAIO J. 2014 May-Jun;60(3):294-9. doi: 10.1097/MAT.0000000000000065.

PMID:
24614355
4.

Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure.

Hottigoudar RU, Deam AG, Birks EJ, McCants KC, Slaughter MS, Gopinathannair R.

Congest Heart Fail. 2013 Jul-Aug;19(4):165-71. doi: 10.1111/chf.12034.

PMID:
23910701
5.

Increased intrathoracic impedance may predict adverse events in LVAD patients.

Bartoli CR, Vessels KM, McCants KC.

J Card Surg. 2013 Sep;28(5):616-8. doi: 10.1111/jocs.12191. Epub 2013 Aug 4.

PMID:
23909444
6.

Treatment of anemia with darbepoetin alfa in systolic heart failure.

Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators.

N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10.

7.

Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD.

Bartoli CR, McCants KC, Birks EJ, Flaherty MP, Slaughter MS.

J Invasive Cardiol. 2013 Mar;25(3):154-6.

8.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators.

Eur J Heart Fail. 2013 Mar;15(3):334-41. doi: 10.1093/eurjhf/hfs204. Epub 2013 Jan 17.

9.

Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.

Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators.

Circulation. 2012 Jun 26;125(25):3191-200. doi: 10.1161/CIRCULATIONAHA.111.058412. Epub 2012 May 22.

10.

Mitral valve prolapse after long-term mechanical ventricular unloading.

Vongooru H, McCants KC, Prabhu SD.

J Heart Lung Transplant. 2011 Sep;30(9):1067-8. doi: 10.1016/j.healun.2011.02.010. Epub 2011 Apr 7. No abstract available.

PMID:
21474339
11.

Heart transplant vs left ventricular assist device in heart transplant-eligible patients.

Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter MS.

Ann Thorac Surg. 2011 May;91(5):1330-3; discussion 1333-4. doi: 10.1016/j.athoracsur.2011.01.062. Epub 2011 Mar 24.

PMID:
21439545
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk